SK
Shrija Konda
About Shrija Konda
Data last updated:
Shrija Konda is a Director at Sai Teja Drugs And Intermidiates Private Limited (since 2024) and Director at Shree Vinayaka Life Sciences Private Limited (since 2024). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹7.26 Cr; the largest is Sai Teja Drugs And Intermidiates Private Limited at ₹5.89 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Sep 2024 | 2000 | ₹5.89 Cr (FY 2025) | Active | |
| Director | 04 Sep 2024 | 2004 | ₹1.36 Cr (FY 2025) | Active |
Board colleagues of Shrija Konda
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shrija Konda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shrija Konda
Shrija Konda currently holds 2 directorships: Sai Teja Drugs And Intermidiates Private Limited (Director, since 04 Sep 2024, revenue ₹5.89 Cr (FY 2025)); Shree Vinayaka Life Sciences Private Limited (Director, since 04 Sep 2024, revenue ₹1.36 Cr (FY 2025)).
Shrija Konda was first appointed on 04 Sep 2024 as Director at Sai Teja Drugs And Intermidiates Private Limited.
The 2 current companies of Shrija Konda that report revenue have a combined latest revenue of ₹7.26 Cr: Sai Teja Drugs And Intermidiates Private Limited ₹5.89 Cr (FY 2025); Shree Vinayaka Life Sciences Private Limited ₹1.36 Cr (FY 2025).
The current boards of Shrija Konda's companies include Bhargav Reddy Kallam (Sai Teja Drugs And Intermidiates Private Limited), Chandrasekhara Reddy Kallam (Sai Teja Drugs And Intermidiates Private Limited), Latha Kallam (Sai Teja Drugs And Intermidiates Private Limited).